Test Price
2,800 AED✅ Home Collection Available
TUBB2B Gene Polymicrogyria Asymmetric Genetic Test in UAE
Executive Summary & Core Metrics
Executive Summary
• Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Sequencing (Cert: INT/EGQ/2509DA/3139).
• Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
• Clinical Guidance: Complimentary telephonic post-test clinical guidance for result interpretation.
• Insurance: Direct Billing Verification via WhatsApp at +971545488731.
Test Overview & Methodology
The TUBB2B Gene Polymicrogyria Asymmetric NGS Test uses Next‑Generation Sequencing to detect pathogenic variants in the TUBB2B gene, which cause asymmetric polymicrogyria – a rare cortical malformation. This test provides a definitive molecular diagnosis with high sensitivity, enabling precise clinical management and genetic counselling.
| Feature | Our TUBB2B NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene & flanking intronic regions | Targeted Sanger sequencing of exons only |
| Diagnostic Precision | 99.9% sensitivity for single nucleotide variants, indels & copy number changes | Lower sensitivity for mosaic/low‑level variants |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Sample Requirements | Whole blood, extracted DNA, or dried blood spot (FTA card) | Whole blood or extracted DNA |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I understand that receiving news about asymmetric polymicrogyria can be overwhelming for families. This NGS-based test provides vital answers for recurrence risk assessment and tailored clinical management. Every result must be interpreted within the full clinical picture by your medical team.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
⚠️ Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results are not an immediate substitute for ongoing therapy and should be used to inform long-term care planning.
Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: This test requires a pre‑test genetic counselling session (as mandated by Federal Decree‑Law No. 4 of 2016 on Medical Liability) and a completed clinical history form; standalone testing without physician referral is not offered.
- Red Flags: If the patient experiences sudden severe headache, unexplained vomiting, altered consciousness, or new‑onset seizures, seek emergency medical attention immediately – these are not related to the testing procedure but may indicate underlying neurological instability.
- Data Privacy: All genetic data is processed in compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields; results are shared only with the referring physician and authorised guardians.
Patient FAQ & Clinical Guidance
1. What does the TUBB2B gene tell us about asymmetric polymicrogyria?
The TUBB2B gene encodes a beta‑tubulin protein essential for neuronal migration; pathogenic mutations disrupt cortical folding, causing asymmetric polymicrogyria. This test identifies those mutations with high precision.
2. How is the NGS test performed and what sample is needed?
We use Next‑Generation Sequencing on a blood sample, extracted DNA, or a dried blood spot card collected via our VIP Mobile Phlebotomy service. Results are ready in 3 to 4 weeks.
3. Is the test covered by insurance and what are the payment options?
We provide direct insurance billing verification via WhatsApp; most UAE plans cover diagnostic genetic testing for neurodevelopmental disorders. Cash and card payments are also accepted.
4. Who will interpret my results and how will I receive them?
A Consultant Medical Genetics (DHA-registered) reviews your report and provides a complimentary telephonic consultation to explain findings and guide next steps. Results are delivered securely via encrypted digital portal.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and complies fully with UAE federal data protection and health information governance frameworks. All genetic data is processed, stored, and transmitted in accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety protocols follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | TUBB2B Gene Polymicrogyria Asymmetric Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene & flanking intronic regions |
| ICD-10-CM Code | Q04.3 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians